All posts by imreal

SweetNight Launches the Perfect Gift for the Holidays – The Eye Tech Mask


Sweet Night Technology Co., Ltd., the company behind the direct-to-consumer sleep brand ‘SweetNight’ has been slowly but surely conquering the U.S. during the last decade with their affordable prices and excellent value-for-money mattresses. Today they are now proud to announce a new product to their new sleep solutions product range: the Eye Tech Mask.

With the Eye Tech Mask, SweetNight gets past sleep boundaries to ensure daytime rest and relaxation not just at home but on the go as well. Powered by a 600mAh battery, with a smart, compact, and foldable design and hypoallergenic, skin-friendly fabric, the mask can be carried and used anywhere, anytime, from home to office, on plane trips, vacations, and more.

Its built-in massage and warm compress features are the perfect solution to soothe tired eyes, relieve stress and screen fatigue, and induce a state of calmness, relaxation, and well-being. And when those are not enough, you have the external ice pocket that can be fitted onto the mask to enjoy a cold compress. Preventing red, swollen eyes and dark circles is as easy as pressing a button!

According to the preliminary feedback, the device also helps relieve insomnia and improve sleep. A few minutes of use before bedtime are a great way to relieve the stress of the day, chase away negative thoughts, and prepare users for bed, helping them fall asleep faster and enjoy deeper, longer sleep. All these beneficial effects make the Eye Tech Mask an amazing gift for the holidays, especially with its unisex design and the average screen time exceeding 7 hours/day for Americans. Who wouldn’t appreciate a few moments of rest and relaxation, especially when delivered stylishly and so conveniently!

“While we still strive to offer the best value for the money, it’s time we showed everyone what our R&D and production teams can do. The Eye Tech Mask is the first step of our gradual expansion from sleep and bedroom products to wellness and lifestyle solutions that we’re sure everyone will appreciate. The next step is a revolutionary mobile wearable blanket launching in December and bound to keep users warm and cozy anytime and anywhere”, said SweetNight Brand Founder, Tony Huang.

SweetNight is a top-rated sleep and wellness brand that uses eco-friendly, certified-quality materials with innovative designs to deliver rest, relaxation, and an improved quality of life at an affordable price.

Share article on social media or email:

Dutch-Based Life-Sciences Company, Detact Diagnostics, Opens First US Operational Lab in New Hampshire


Detact Diagnostics, a life-sciences company that develops diagnostic tests for the health & food sector, opened its first U.S. operational laboratory in Keene, N.H. Courtesy of Detact Diagnostics.

“New Hampshire’s robust life science sector continues to attract companies developing groundbreaking technology, treatments and detection solutions,” said BEA Commissioner Taylor Caswell. “The expansion further enhances our economy by creating jobs, opportunities and resources for the community.”

New Hampshire Department of Business and Economic Affairs(BEA) announced today that Detact Diagnostics, a Dutch-based life-sciences company that develops diagnostic tests for the health and food sector, opened its first U.S. operational laboratory in Keene, New Hampshire. Located in Keene State College’s Putnam Science Center, the lab will serve as a diagnostics research and development space, with plans to roll out bacterial diagnostics clinical testing in the coming months once it receives federal certification.

“New Hampshire’s robust life science sector continues to attract companies developing groundbreaking technology, treatments and detection solutions,” said BEA Commissioner Taylor Caswell. “This expansion further enhances our economy by creating jobs, opportunities and resources for the growing biotech community in the Granite State, while also attracting new talent and companies. Successful programs and business opportunities like this one are possible because of our ‘triangle’ strategy – the collaboration among our academic institutions, employers, and state and local economic development agencies.”

The patented Detact Diagnostics platform technology called VIPER® (Visualization by Infrared Peptide Reaction) involves the immediate release of a quenched Near Infrared (NIR) molecule from its peptide bond after contact with a specific bacteria/enzyme, which emits NIR-light (NIRL). The amount of light released determines the presence of bacteria or viruses. Due to its speed, precision and sensitivity, even with very diluted samples, the potential of this technology is superior compared to other testing products.

The company plans to hire Keene State College students for academic internship opportunities each semester and will roll out multiple hiring incentive programs in partnership with the institution.

The expansion is in conjunction with the Hannah Grimes Center for Entrepreneurship’s BioNest program, which provides targeted biotech support along with their core programming for entrepreneurs and companies in the state’s rural Monadnock Region.

“We couldn’t have selected a better location for our U.S. headquarters,” said Joost Gazendam, CEO of Detact Diagnostics. “From the support we received from Hannah Grimes to the region’s growing life science community and access to a booming workforce, there are endless aspects that drew us to New Hampshire.”

In the coming months, the laboratories at Keene State College will be certified by the Clinical Laboratory Improvement Amendment (CLIA), which recognizes laboratories that are certified by the Center for Medicare and Medicaid Services which regulates labs researching human specimens to ensure that they provide accurate, reliable and timely tests. The facilities will allow for fast, affordable and precise treatment and will attract biotech companies to the state.

New Hampshire’s life science industry is a leading driver of economic growth in the state. The life science and medical device sector includes over 600 companies, employs over 7,000 people and contributes nearly $6 billion to New Hampshire’s gross domestic product (GDP).

About Detact Diagnostics

Detact Diagnostics is a life-science company based in the Netherlands, founded in 2014 by former trauma surgeon Joost Gazendam, MD, PhD. Seeking to develop diagnostics to detect the presence of post-surgical infection, Gazendam and team developed a novel and disruptive bacterial-detection platform/technique, VIPER®, that is both highly sensitive and specific to pathogens, and thus, uniquely suited to developing quick, affordable point-of-care tests. Detact is advancing its applications in healthcare and food safety. For more information, visit: https://www.detactdiagnostics.com.

About the New Hampshire Department of Business and Economic Affairs (BEA)

The Department of Business and Economic Affairs is dedicated to enhancing the economic vitality of the state of New Hampshire while promoting it as a destination for domestic and international visitors. For more information, visit http://www.nheconomy.com or http://www.choosenh.com.

Share article on social media or email:

Rimidi Named to 2022 CB Insights’ Digital Health 150 List


News Image

The recognition is truly a testament to the work our team is doing to improve care coordination and collaboration for our customers and within the industry at large.

Driven in part by the company’s recent and rapid growth and expansion, Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, announced today it has been named to CB Insights’ Digital Health 150 list.

Utilizing the CB Insights platform, the research team selected the top 150 winners from a pool of over 13,000 private companies, including applicants and nominees. Companies were chosen based on factors including R&D activity, proprietary Mosaic scores, market potential, business relationships, investor profile, news sentiment analysis, competitive landscape, team strength, and tech novelty. The research team also reviewed over 3,000 Analyst Briefings submitted by applicants.

“From reimagining clinical care, to leveraging tech like AR/VR to improve surgical training, this year’s Digital Health 150 winners are transforming the future of healthcare with digital technology,” said Brian Lee, SVP of CB Insights’ Intelligence Unit. “This increasingly global cohort, representing more than 18 countries across five continents, is not only driving better patient outcomes, but making healthcare more accessible. We are excited to follow the meaningful impact and continued success of this year’s winners.”

Digital health adoption continues to accelerate, with the digital health market size is expected to hit $1.5 trillion by 2030. As new devices and digital therapeutics come to market, clinicians will need a way to synthesize the growing amounts of data in a meaningful way that impacts patient care. Rimidi’s clinical management platform is meeting this need by bringing data from the latest innovations into the clinical workflow and supporting clinicians with guideline and patient-specific clinical decision support.

In addition to being recognized on the Digital Health 150 List, Rimidi was also recently named to AVIA Connect’s Top 50 Companies in Remote Patient Monitoring Report. Furthermore, the company’s entry to the 2022 American Medical Informatics Association(AMIA)/HL7 FHIR Applications competition, “Managing Postpartum Hypertension with Rimidi’s FHIR-enabled Cardiometabolic Management Platform” came in second place in this year’s competition.

“I could not be more proud of the entire Rimidi team for our great accomplishment of making this year’s CB Insights’ Digital Health 150 List. The recognition is truly a testament to the work our team is doing to improve care coordination and collaboration for our customers and within the industry at large,” said Lucienne Ide, MD, PhD, Founder and CEO of Rimidi. “Now in our tenth year of business, we’re more committed than ever to furthering our mission of helping clinicians optimize data for better care, and we’re ready to hit the ground running in 2023 and beyond.”

For more information on Rimidi, its solutions, and to stay abreast of upcoming news and updates, visit http://www.rimidi.com.

About Rimidi

Created by doctors, Rimidi’s leading clinical management platform empowers healthcare organizations to optimize clinical workflows, enhance patient experiences and achieve quality objectives. By bringing together clinical decision support, remote patient monitoring and patient-reported outcomes in a unified, composable, FHIR-based platform, Rimidi supports a broad range of clinical use cases and institutional priorities across large and small healthcare organizations. For more information, visit rimidi.com and follow us on Twitter and LinkedIn.

Share article on social media or email:



2Gether-International Awards $10K in Seed Funding to Artin Perse, Founder of Digital Health Startup Levl, Winner of the 2022 BIPOC Cohort Pitch Competition


2Gether-International is the leading startup accelerator in the nation run by and for entrepreneurs with disabilities

2Gether-International (2GI), the leading startup accelerator in the nation run by and for entrepreneurs with disabilities, is proud to announce the winner of the 2022 BIPOC Cohort Pitch Competition: Artin Perse, Founder and CEO of Levl, a digital health startup on a mission to de-stigmatize mental health treatments and to empower people to find balance with their mental health. Levl’s smart device and app work together to help users correctly take medication, track symptoms, and earn rewards for staying on top of the treatment.

Artin took part in 2Gether-International’s BIPOC Tech Cohort Accelerator powered by Comcast NBCUniversal. The Cohort included 11 participants, all Black, Indigenous and people of color (BIPOC) individuals with disabilities and founders of early-stage, high-growth, tech startups, who were immersed in 2GI’s 10-week accelerator program designed to develop their businesses further. On December 13, six semi-finalists from the program, selected for their outstanding business foundation and potential, came together for the Cohort’s cumulative virtual pitch competition, an opportunity to showcase their businesses and win seed funding. This opportunity was also made possible with support from Comcast NBCUniversal.

The six semi-finalists and their respective companies included:

The pitch competition also featured a panel of industry experts serving as judges including:

  • Miller Adams, Managing Partner at Pier 70 Ventures
  • Chris Denson, Award-Winning Innovation Advisor & Consultant
  • Aston Pierce, Associate at Edison Partners
  • Deepika Jonnalagadda, Analyst at Blu Ventures
  • Alana Mann, Partner at Latimer Ventures
  • Regina Green, Vice President at Goldman Sachs Asset Management

“Congratulations to this incredible cohort of innovators and leader who are setting the precedent for inclusion,” said Juan Otero, SVP of Diversity, Equity, and Inclusion at Comcast Corporation. “We have long championed inclusion for individuals with disabilities and through our deepened commitment to digital equity, we imagine a world of unlimited possibilities. That’s why we’re

proud to partner with 2GI to support pathways to success for so many outstanding visionaries.”

Since its launch in 2020, graduates of other 2GI Accelerators have collectively raised over $41 million dollars in funding from investment, revenues and acquisitions. “We’re so proud to have worked with all of the trailblazing founders who are not only innovating in their respective industries but also exemplifying how disability can be a competitive advantage for startups all around the world,” said Diego Mariscal, Founder, CEO & Chief Disabled Officer of 2GI. “These entrepreneurs are living examples of what overlooked communities can accomplish when they have access to the proper resources and support.”

2Gether-International aims to address the employment and entrepreneurship gap for both disability and BIPOC individuals, and help set the stage for visionary founders from these communities to access investment capital. For more information on 2Gether-International and its Accelerator Cohort programs, visit https://2gether-international.org/.

About 2Gether-International (2GI):

2Gether-International is the leading startup accelerator run by and for entrepreneurs with disabilities. 2GI supports high-growth, high-impact startups, led by founders with disabilities. Through this work, 2GI highlights disability as a competitive advantage for businesses. Learn more about 2GI and their accelerator programs here: https://2Gether-international.org/

About Comcast Corporation:

Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company that connects people to moments that matter. We are principally focused on connectivity, aggregation, and streaming with 57 million customer relationships across the United States and Europe. We deliver broadband, wireless, and video through our Xfinity, Comcast Business, and Sky brands; create, distribute, and stream leading entertainment, sports, and news through Universal Filmed Entertainment Group, Universal Studio Group, Sky Studios, the NBC and Telemundo broadcast networks, multiple cable networks, Peacock, NBCUniversal News Group, NBC Sports, Sky News, and Sky Sports; and provide memorable experiences at Universal Parks and Resorts in the United States and Asia. Visit http://www.comcastcorporation.com for more information.

Share article on social media or email:

SafetyStratus Launches EHS Spark for Production Release Notes


“We are always looking for ways to enhance our services by listening to our community and making not just the necessary adjustments, but the ones that best serve others.” -Greg Kwolek

SafetyStratus, the user-friendly enterprise EH&S software company, announced today the release of EHS Spark, a dedicated webpage for software production release notes. Building on the storehouse of SafetyStratus’ knowledge network, this addition extends the functional, collaborative content with enhanced documentation around changes, updates, and improvements. The release notes define important work done as a result of changing regulatory requirements and feedback from the current community members as they utilize SafetyStratus software to handle everyday work challenges.

This technical documentation has been separated into categories of “Changes” and “Updates,” spelled out in everyday language, and organized into separate color pallets for easy intake. Whenever SafetyStratus launches a new module or a product update, these enhancements will be succinctly detailed on EHS Spark. The team at SafetyStratus hopes that presenting this information to the public will be a valuable opportunity for partner and safety professional communications. With more prevalent safety conversations, we can accelerate the discovery and adoption of technologies that help mitigate workplace risks and adapt to changing regulations.

Greg Kwolek, Director of Product Management at SafetyStratus, says “Our ultimate goal is to optimize the processes around safety. Optimization necessitates constant feedback and improvement.” On the EHS Spark webpage, the production release notes’ description conveys that idea: “feedback transformed into product improvements.” Referring to the work done as part of a holistic effort to adapt SafetyStratus modules to specific company requirements or requests, Kwolek also stated, “We are always looking for ways to enhance our services by listening to our community and making not just the necessary adjustments, but the ones that best serve others.” To contribute input to the conversation of how we can all collaborate for a safer future, we invite the user community to “join the conversation” on the SafetyStratus webpage, or subscribe to receive notifications for updates to the different resources within the Knowledge Network.

To view the EHS Spark webpage, click here.

About SafetyStratus

==================

SafetyStratus is designed by EH&S professionals for EH&S professionals. Our multi-level technology platform brings user-friendly, practical innovation to Environmental, Health, and Safety management in Academia, Healthcare, Construction, and Manufacturing. Our aim is to always be learning. We save lives and the environment by successfully integrating knowledgeable people, sustainable processes, and transformative technology.

SafetyStratus has headquarters located in Plano, TX with an employee base of industry experts and leaders, spanning the globe.

For more information visit http://www.safetystratus.com or LinkedIn, Twitter, and Facebook.

Share article on social media or email:



MD Logic Health and Melanie Avalon Launch Berberine 500 to Expand AvalonX Line


“I’m so grateful that, with MD Logic Health, we were able to create a pure, potent, and powerful berberine supplement that meets the uncompromising standards my community expects and deserves.” – Melanie Avalon

MD Logic Health (“MD Logic”), a leading provider of USA-made professional-grade nutraceuticals and physician-recommended dietary supplements announced the latest AvalonX powered by MD Logic Health dietary supplement: Berberine 500. AvalonX, founded by Melanie Avalon, was built on a mission of purity, potency, transparency, and trust, and is quickly becoming the standard for Avalon’s fans, and others in the health-focused community.

With the launch of Berberine 500, AvalonX and MD Logic continue to create products unmatched in quality and purity. To formulate AvalonX supplements, MD Logic innovated a small batch production process, to support Avalon’s vision to create clean, environmentally friendly, pure supplements. AvalonX products contain ethically sourced, laboratory-tested raw ingredients. The raw ingredients remain isolated from the production facility until they have passed the compliance multistage lab analysis for identity, purity, strength, composition, and contaminants. The final product is tested again for these same core quality controls.

Berberine 500 is vegan and features a single active ingredient from the Berberis Aristata root. It contains no rice fillers, stearates, palmitates, dyes, hidden proprietary ingredients, or GMOs. While Berberine 500’s source certification indicated pesticide-free, Melanie Avalon insisted on conducting additional third-party tests for pesticides.

“Rising blood sugar levels are a key factor in metabolic syndrome and the obesity epidemic, and the standard American diet contains a significant amount of processed carbohydrates, which often spike blood sugar levels. I wanted to make a product that would help my audience in their pursuit of healthy glycemic control. We knew berberine, which has been used in Ayurveda medicine for thousands of years, had to be the next product launch, after our overwhelming success with our Serrapeptase 125 and Magnesium 8,” says Avalon.

“I’m so grateful that, with MD Logic Health, we were able to create a pure, potent, and powerful berberine supplement that meets the uncompromising standards my community expects and deserves.”

MD Logic Health COO and Cofounder Scott Emmens commented, “Berberine 500 is the masterpiece of collaboration with our partner Melanie Avalon. It is a uniquely produced berberine which I am very proud to have been a part of developing, and look forward to using it daily! Our partnership continues to deliver new innovations and quality dietary supplements to Melanie’s amazing fans and our MD Logic community. Our team works tirelessly to serve the AvalonX and MD Logic Health communities to produce pure, clean, sustainable supplements. I am so thankful for the tremendous support from our healthcare community and customers.”

About Melanie Avalon

Melanie Avalon is the host of The Intermittent Fasting Podcast with TEDx speaker and nurse practitioner Cynthia Thurlow, and The Melanie Avalon Biohacking Podcast, on which she interviews the world’s top doctors, authors, and researchers. Avalon’s shows have been featured in USA Today, LA Weekly, Entrepreneur, and many other news outlets, and net 700k+ monthly downloads. Avalon is also the author of What When Wine: Lose Weight and Feel Great with Paleo-Style Meals, Intermittent Fasting, and Wine, and creator of the top Apple app “Food Sense Guide.” Her thriving Facebook communities include 13K+ members. To learn more, visit https://melanieavalon.com.

Follow Melanie Avalon

Instagram: @melanieavalon

Twitter: @melanieavalon

LinkedIn: linkedin.com/in/melanieavalon

Facebook: http://facebook.com/missmelanieavalon

Facebook Groups:

IF Biohackers: Intermittent Fasting + Real Foods + Life

Lumen, Biosense & CGMs: Carbs, Fat, Ketones & Blood Sugar

Clean Beauty And Safe Skincare With Melanie Avalon

About MD Logic Health – Supplementing Life since 2005

MD Logic Health was founded in 2005 by Dr. Steinfeld, who recognized the importance of providing access to professional-grade, pure, high-quality nutrients as part of his patients’ overall health care. MD Logic remains dedicated to providing integrated healthcare professionals and patients with the highest-grade nutraceuticals. MD Logic Health products are manufactured under USA Good Manufacturing Standards, using sustainable resources and rigorously tested ingredients. MD Logic Health supports access to nutraceuticals, education, and awareness for today’s integrated healthcare provider and patient. MD Logic Health has been featured on CBS, ABC, NBC, and CW. To learn more, please visit https://www.mdlogichealth.com.

Follow MD Logic Health

Instagram: @mdlogichealth

Twitter: @mdlogichealth

LinkedIn: linkedin.com/company/md-logic

Facebook: facebook.com/mdlogichealth

TikTok: @mdlogichealth

MD LOGIC HEALTH CONTACT:

Jyoti Hardat

jhardat@mdlogichealth.com

Phone (877) 629-8711 x700

AVALONX CONTACT:

Melanie Avalon

contact@avalonx.us

Share article on social media or email:



Shriners Children’s Northern California Becomes Second in Nation to Achieve Highest Level of Musculoskeletal Surgical Verification


Shriners Children's doctor and patient doing orthopedic visit

Maya Evans, M.D., conducting a physical medicine and rehabilitation visit with a patient.

“This Level I verification is extremely meaningful to us at Shriners Children’s, because it reflects our continual efforts to provide high-quality care to more children, closer to where they live.”

Shriners Children’s Northern California is the second pediatric hospital in the nation to obtain verification as a Level I Specialty Children’s Surgery-Musculoskeletal Surgery Center by the American College of Surgeons (ACS), and the only facility on the west coast. The Level I verification is the highest of 3 levels of ACS surgical verification a pediatric hospital can receive.

Level I Specialty Children’s Surgery-Musculoskeletal verification requires pediatric hospitals to meet strict standards, demonstrating that patients receiving surgery receive care under a multidisciplinary program while ensuring safety standards and processes, meticulous data collection, high quality improvement and appropriate surgical resources. The verification followed an extensive review of hospital structure, processes, and outcomes conducted by a team of ACS surveyors including experienced pediatric surgeons, anesthesiologists and nurses.

“This Level I verification is extremely meaningful to us at Shriners Children’s, because it reflects our continual efforts to provide high-quality care to more children, closer to where they live,” said Jerry G. Gantt, Shriners Children’s Chairman of the Board of Trustees. “We are committed to providing hope and healing to the patients who come to Shriners Children’s Northern California for surgical services.”

The Shriners Hospitals for Children healthcare system has a long history of delivering exceptional pediatric care, through its three-part mission of caring for patients with the highest quality care, conducting research to gain knowledge and develop new treatments and providing educational opportunities for physicians and the next generation of healthcare professionals.

“We are honored to be only one of two pediatric hospitals in the nation with this verification,” said Chief of Orthopedics, Michelle James, MD. “This verification from the American College of Surgeons reflects our organization’s commitment to providing individualized, patient-centered, high-quality care and experience for the families we serve. It confirms to parents and healthcare professionals that, for their children and patients, the highest level of musculoskeletal care available in the nation can be received here.”

Shriners Children’s Northern California is ranked by U.S. News and Report as one of the top orthopedics program in the country, in partnership with UC Davis Children’s Hospital. Shriners Children’s Northern California’s signature clinical programs within orthopedics includes fracture follow-up and care, hand and upper extremity program, lower extremity care, multidisciplinary neuromuscular programs, spine and scoliosis care and sports medicine. Patients receive care from a multi-disciplinary team of surgeons, anesthesiologists, nurse practitioners, psychiatrists and psychologists, burn technicians, occupational and physical therapists, nutritionists, social workers, pharmacists, child life specialists and orthotists. Shriners Children’s continues to serve on their mission of treating any patient who qualifies for care regardless of their ability to pay or insurance status.

About Shriners Children’s:

Shriners Children’s is changing lives every day through innovative pediatric specialty care, world-class research and outstanding medical education. Our multiple locations in the United States, Canada and Mexico provide advanced care for children with orthopedic conditions, burns, spinal cord injuries, and cleft lip and palate. All care is provided regardless of the families’ ability to pay. Shriners Children’s has treated more than 1.5 million children from more than 170 countries over the last 100 years.

For more information on the care provided by Shriners Children’s, go to shrinerschildrens.org

Shriners Hospitals for Children is a 501(c)(3) nonprofit organization and relies on the generosity of donors. All donations are tax deductible to the fullest extent permitted by law.

Share article on social media or email:

Air Animal Recommends Canine Flu Vaccine Before Relocation, Travel or Dog Groomer Visits


Two pups out for a social day at the Dog Days of Summer Concert. Photo by Thompson Brand Images.

Social pups should be vaccinated for canine influenza. It’s highly contagious between dogs. Dog flu can cause pneumonia and death.

A canine influenza outbreak is spreading across the southern U.S.—Tennessee, Texas. South Carolina, Alabama and elsewhere. It can quickly spread around the world because more people now travel and relocate with their pets. Air Animal urges all dog parents to vaccinate their dogs against canine influenza before relocating, traveling or any visit outside the home.

“People take their dogs with them everywhere today,” warns Walter M. Woolf, VMD, founding veterinarian and CEO at Air Animal Pet Movers. “Going to the dog park, the veterinarian, the dog groomer or doggie daycare can expose your precious fur baby to canine influenza. Flu in dogs is potentially dangerous and very contagious. It does not currently pose a risk for people.”

Like flu in humans, canine influenza is spread through aerosols and respiratory droplets.

“Dog flu is easily prevented by vaccinating your dog with two doses of the canine flu vaccine,” Woolf explained. “Ask your veterinarian about the vaccine. The first shot provides partial immunity. The second shot given about two weeks later is a booster which gives stronger protection.”

There are two types of canine influenza vaccines. Ask your veterinarian which she recommends.

  • Zoetis – Vanguard CIV H3N2/H3N8 – 2 vaccinations, 3 weeks apart. Considered fully vaccinated 7 days after the second shot.
  • Merck – Nobivac CIV H3N2/H3N8 – 2 vaccinations, 2 weeks apart. Considered fully vaccinated 14 days after the second shot.

For people relocating overseas with their dogs, New Zealand, Australia and other countries now require dog flu vaccination, according to Woolf. These countries usually accept a recent booster shot if the documents show full previous immunization and the booster administration date.

Dogs that come down with the flu develop fevers and coughs that last one to three weeks. Dog parents may notice decreased appetite, lethargy and a greenish discharge from the nose and eyes. Some dogs develop higher fevers and pneumonia. Severe dog flu cases cause death.

For people traveling or taking their dogs anywhere outside the home–especially to an overseas destination—canine flue vaccination is an ounce of prevention that really is better than a pound of cure.

Learn more about country requirements for importing pets at airanimal.com.

About Air Animal

Air Animal has helped more than 55,000 families move their 135,000 furry, feathered and scaly pets around the globe since 1977. They welcome pet move authorizations and referrals from major corporations, relocation management agencies, household goods movers, veterinarians, families, U.S. military and government transferees. Get the best in animal care and transportation. Air Animal is an appointed and endorsed IATA air cargo sales agency working with all airlines that move animals. They are an Indirect Air Carrier cleared for tendering live animals to airlines by the U.S. Transportation Security Administration. See airanimal.com to learn more about Pet Moving Made Easy®.

Share article on social media or email:

11th Chief Medical Officer Summit 360° Agenda and Keynotes Announced from The Conference Forum


The two-day CMO Summit has over 60 biotech Chief Medical Officers speaking in over 40 sessions. We are grateful to the support of this incredible community of R&D leadership representing biotechs of all therapeutic areas.

The Conference Forum is pleased to announce the agenda and keynote speakers for the 11th annual Chief Medical Officer Summit 360°, the only conference dedicated to supporting the role of the Chief Medical Officer in emerging biotechs. The CMO Summit 360° will take place in Boston on April 4-5.

“The two-day CMO Summit has over 60 biotech Chief Medical Officers speaking in over 40 sessions. We are grateful to the support of this incredible community of R&D leadership representing biotechs of all therapeutic areas,” says Andrew Goldstein, Senior Conference Producer for the CMO Summit 360°.

Dr John Maraganore, Founding CEO of Alnylam Pharmaceutical is the CEO keynote. Dr Maraganore will share highlights and lessons learned from his 19 years as a CEO leading a team that conquered some very difficult drug development challenges and how he worked with his senior level R&D leadership.

The state of the drug development industry keynote address will be given by Ken Getz, MBA, Deputy Director of Sponsored Research, Tufts CSDD, and Founder of CISCRP.

The CMO Summit 360°’s Founding Advisor, Dr Elizabeth Stoner, Executive Partner at MPM Capital, will share some opening remarks as well as provide a snapshot on what investors look for in a CMO and the biotech investment landscape.

Additionally, for the first time at the CMO Summit 360°, there will be a series of fireside discussions between CMOs and their C-suite colleagues on how they communicate and collaborate cross-functionally.

Key topic areas for 2023 covered include: biotech finance and business development, trends and technologies in clinical development, regulatory best practices, organizational management, internal relationships and team building, communication strategies, professional development for CMOs and more.

The Chief Medical Officer Summit 360°brings together CMO and R&D executives to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital and strategizing for appropriate exits. It is the annual Boston gathering for R&D leadership networking from small to mid-size biotechs to share ideas, solutions and support.

To learn more about the event, please visit https://theconferenceforum.org/conferences/chief-medical-officer-summit/overview/

About the Conference Forum:

The Conference Forum is a life science industry research firm that develops conferences, podcasts, newsletters and webinars primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high-quality networking. Learn more about the Conference Forum at theconferenceforum.org.

Share article on social media or email:

Dallas Plastic Surgeon Dr. Rod J. Rohrich Honored as Texas Monthly Super Doctor


Dallas plastic surgeon Dr. Rod J. Rohrich

Dallas plastic surgeon Dr. Rod J. Rohrich

“Surgeon selection is the single most influential factor for ensuring a successful outcome in plastic surgery.”

Dallas plastic surgeon and rhinoplasty specialist, Dr. Rod J. Rohrich, has been recognized as one of the best plastic surgeons in Texas for 2022 by Texas Monthly’s annual list of outstanding physicians.

The Super Doctor award is granted to exceptional physicians based on nominations by colleagues practicing in their specialty and within their region. The highest rated nominees are then reviewed by a panel of peers based on 10 areas of professional excellence and achievements. These include years of experience, professional honors, board certifications, academic accomplishments, and teaching roles. Candidates are also rated on their involvement in scientific publications, medical research, participation in lectures, and other professional activities.

Based on his extensive ongoing work in these areas, Dr. Rohrich, whose clinical practice focuses on aesthetic plastic surgery such as rhinoplasty, revision rhinoplasty, and facelift surgery, has been designated as a Super Doctor for the 18th consecutive year. According to their website, the Super Doctor award is only granted to approximately the top five percent of regional medical specialists.

“Rigorous awards such as Super Doctors can be a valuable resource for patients who are evaluating their options,” says Dr. Rohrich. “Surgeon selection is the single most influential factor for ensuring a successful outcome in plastic surgery.”

Dr. Rohrich is a longstanding advocate for patient safety and his innovative approach to maximizing both consistency and excellence in both primary and revision rhinoplasty. A significant part of his practice consists of secondary or revision nasal surgeries, often for patients who have had poor results from their primary surgeries. Over half of his rhinoplasty patients in Dallas, for example, come to him seeking revision rhinoplasty – corrective surgery from a previous rhinoplasty that had an unsatisfactory outcome.

“The single most important factor in all of plastic surgery is who you select as your surgeon,” says Dr. Rohrich. “Patients should always do their research and choose their surgeon carefully. Make sure he or she is board certified by a specialty of the American Board of Medical Specialties, and has the expertise and the experience to deliver a safe and satisfactory outcome.” He emphasized the 3 Es for finding the best plastic surgery expert – Experience, Expertise, and the ability to deliver consistently Excellent results.

About Rod J. Rohrich, M.D., F.A.C.S.

Dr. Rod J. Rohrich is a board certified plastic surgeon in Dallas, Texas. He is considered one of the most influential surgeons in this century. He was named the top plastic surgeon in America by Newsweek in both rhinoplasty and facelift surgery in 2021 and 2022. Dr. Rohrich is a Clinical Professor of Plastic Surgery at Baylor College of Medicine. He was the first Chair of the Department of Plastic Surgery as well as the first plastic surgeon selected as a Distinguished Teaching Professor at UT Southwestern Medical Center. He graduated from Baylor College of Medicine with high honors, and completed his plastic surgery training at the University of Michigan Medical Center and fellowships at Massachusetts General Hospital/Harvard (hand/microsurgery) and Oxford University (pediatric plastic surgery). He is Chair of the Dallas Rhinoplasty Meeting, Founding Chair of the Dallas Cosmetic Surgery and Medicine Meeting, Founding Member of the Alliance in Reconstructive Surgery, and a Founding Partner of the Dallas Plastic Surgery Institute.

He is the immediate past (after serving for 18 years) past Editor-in-Chief of the most respected global peer reviewed plastic surgery journal – the Plastic and Reconstructive Surgery Journal. He is Founding Editor-in-Chief/Editor Emeritus of the first open access peer reviewed plastic surgery journal, PRS Global Open. Dr. Rohrich has published over 1000 peer reviewed articles and seven textbooks in plastic surgery including a best-selling medical book entitled The Facial Danger Zones. Dr. Rohrich recently published an innovative cosmetic surgery video atlas, Cosmetic Surgery by the Masters.

Dr. Rohrich also served as president of the American Society of Plastic Surgeons (ASPS), the largest organization of board certified plastic surgeons in the world. He repeatedly has been selected by his peers as one of America’s best doctors. He received the ASPS Special Achievement Award and on three occasions has received one of his profession’s highest honors, the Plastic Surgery Foundation (PSF) Distinguished Service Award, which recognizes his contributions to education in plastic surgery. In addition, he has also been recognized by the PSF with the Plastic Surgery Foundation Distinguished Career Researcher Award for his contributions to plastic surgery research and innovations. He is also the recipient of the ASPS 2022 Honorary Citation.

Share article on social media or email: